Document Detail

BNNT-Mediated Irreversible Electroporation: Its Potential on Cancer Cells.
MedLine Citation:
PMID:  22475064     Owner:  NLM     Status:  Publisher    
Irreversible lethal electroporation (IRE) is a new non-thermal ablation modality that uses short pulses of high amplitude static electric fields (up 1000 V/cm) to create irreversible pores in the cell membrane, thus, causing cell death. Recently, IRE has emerged as a promising clinical modality for cancer disease treatment. Here, we investigated the responses of tumour human HeLa cells when subjected to IRE in the presence of BNNTs. These consist of tiny tubes of B and N atoms (arranged in hexagons) with diameters ranging from a 1 to 3 nanometres and lengths < 2 μm. BNNTs have attracted wide attention because of their unique electrical properties. We speculate that BNNTs, when interacting with cells exposed to static electrical fields, amplify locally the electric field, leading to cell death. In this work, electroporation assays were performed with a commercial electroporator using the cell- specific protocol suggested by the supplier (exponential decay wave, time constant 20 ms) with the specific aim to compare IRE in absence and in presence of BNNTs. We observed that BNNTs have the capacity to decrease substantially the voltage required for IRE. When cells were pulsed at 800 V/cm, we observed a 2,2-fold reduction in cell survival in the presence of BNNTs compared to controls. We conclude that the death of the tumour cells exposed to IRE is strongly enhanced in the presence of BNNTs, indicating their potential therapeutic application.
V Raffa; C Riggio; M W Smith; K C Jordan; W Cao; A Cuschieri
Related Documents :
24891214 - The chlamydial anomaly clarified?
1596484 - Foamy transformed gaucher cells.
10392904 - Oncogene expression cloning by retroviral transduction of adenovirus e1a-immortalized r...
8248164 - Cellular epigenetics: effects of passage history on competence of cells for "spontaneou...
4929864 - Impaired transduction of r213 and its recovery by a homologous resident r factor.
9950214 - Two alternatively spliced meig1 messenger rna species are differentially expressed in t...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-28
Journal Detail:
Title:  Technology in cancer research & treatment     Volume:  -     ISSN:  1533-0338     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-4-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101140941     Medline TA:  Technol Cancer Res Treat     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Life Science Institute, Scuola Superiore Sant'Anna, Pisa, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  CyberKnife Radiosurgery for the Treatment of Orbital Metastases.
Next Document:  Targeting Liposomal Nanomedicine to Cancer Therapy.